Mechanism ID'd for benefit of stem cells in autoimmunity

Mechanism ID'd for benefit of stem cells in autoimmunity
Bone marrow mesenchymal stem cells activate a mechanism involving coupling of FAS/FAS ligand to induce T cell apoptosis and immune tolerance, according to an experimental study published online April 26 in Cell Stem Cell.
(HealthDay) -- Bone marrow mesenchymal stem cells (BMMSCs) activate a mechanism involving coupling of FAS/FAS ligand to induce T cell apoptosis and immune tolerance, according to an experimental study published online April 26 in Cell Stem Cell.

To investigate the mechanisms underlying the therapeutic benefit of BMMSCs in autoimmune disease, Kentaro Akiyama, D.D.S., Ph.D., from the University of Southern California in Los Angeles, and colleagues infused BMMSCs into mice.

The researchers found that, in mice models of systemic sclerosis or experimental colitis, infusion of BMMSCs induced T via the FAS ligand-dependent FAS pathway, and reduced symptoms of the disease. This was not seen in BMMSCs not expressing the FAS ligand. The apoptotic T cells triggered macrophages to produce transforming growth factor-β which upregulated CD4+CD25+Foxp3+ regulatory T cells leading to . In five patients with systemic sclerosis who received a transplant of allogenic , disease symptoms improved and the FAS pathway was involved.

"These data therefore demonstrate a previously unrecognized mechanism underlying BMMSC-based immunotherapy involving coupling via FAS/FAS ligand to induce T cell apoptosis," Akiyama and colleagues conclude.


Explore further

Recipient's immune system governs stem cell regeneration

More information: doi 10.1016/j.stem.2012.03.007

Copyright © 2012 HealthDay. All rights reserved.

Citation: Mechanism ID'd for benefit of stem cells in autoimmunity (2012, May 2) retrieved 18 March 2019 from https://medicalxpress.com/news/2012-05-mechanism-idd-benefit-stem-cells.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more